{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Saddle Brook",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82337",
      "recalling_firm": "Rising Pharmaceuticals, Inc.",
      "address_1": "250 Pehle Ave Ste 601",
      "address_2": "N/A",
      "postal_code": "07663-5832",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 6 major distributors who may have further distributed the product throughout the United States.",
      "recall_number": "D-1052-2019",
      "product_description": "Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC,  Saddle Brook, NJ, Manufactured by: Aurolife Pharma LLC, Dayton, NJ ---- NDC 52343-122-30",
      "product_quantity": "30,530 bottles",
      "reason_for_recall": "CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products",
      "recall_initiation_date": "20190307",
      "center_classification_date": "20190321",
      "report_date": "20190327",
      "code_info": "470170038A, exp. date 10/31/2019  470180010A, exp. date 02/29/2019  470180012A, exp. date 03/31/2020"
    }
  ]
}